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Summary
T cell clones recognizing the sperm whale myoglobin (SpWMb) epitope 110-121 in association
with H-2d major histocompatibility complex class II molecules display a very limited
heterogeneity of T cell receptor (TCR) VO usage in DBA/2 mice. All clones previously tested
used the same V(3 8.2 gene segment and very restrictedjunctional regions. To investigate the
significance of this observation in vivo, we immunized DBA/2 mice with the intact SpWMb
protein or peptide 110-121. Only the V#8+ T cells showed any significant response to the 110-
121 epitope. The response to peptide 110-121 was then analyzed in mice which, either as a
consequence of antibody depletion or through genetic deletion of TCR V0 genes, lacked V08+
peripheral T cells. DBA/2 mice depleted of V08+ T cells by antibody treatment responded
poorly to the 110-121 peptide, and only at high antigen concentrations. In contrast, DBA/2Vf'
mice (homozygous for a deletion ofmultiple VO gene segments including the V#8 family) made
a response at least as great as that made by DBA/2 mice, even though the DBA/2V0°mice
had a very restrictedTCR Vii repertoire compared with DBA/2 mice. Mechanisms which might
determine differences in the 110-121 specific response of DBA/2, DBA/2VO, and F23.1-treated
DBA/2 mice are discussed.
T
he T cell receptor, a heterodimeric glycoprotein com-
posed of an a and 0 chain expressed on the cell surface
of T lymphocytes, is responsible for recognition of antigen
fragments associated with proteins of the MHC (1-3). The
a and $ chains are encoded by a series of V, D, and J ele-
ments which recombine during thymocyte ontogeny to pro-
duce functional TCR genes (1) . The three dimensional struc-
ture of the TCR has not yet been determined and the way
in which the use of particular TCR gene segments deter-
mines specificity remains unknown. There have been several
reports where use of particular TCR Va (4-9) or V/3 (4,
5, 7-10) gene segments correlated with antigen or MHC rec-
ognition. T cell clones responding to a given epitope often
exhibit limited heterogeneity ofrearranged V andJ segments
(4, 5, 9, 11-14). It is not possible, however, to make general
correlations between the use of particular TCR gene seg-
ments and antigen/MHC specificity. In this study, we have
asked whether the dominant TCR V(3 gene usage observed
in the response to a well characterized epitope is determined
by structural constraints or by more complex events affecting
the available TCR repertoire.
Our analysis of TCR sequences from a panel of DBA/2
(H-2d) T cell clones specific for sperm whale myoglobin
(SpWMb)' has shown that the T cell response to the epi-
tope 110-121, restricted by the isotype hybrid molecule
AgdEad (Ruberti, G., K.S. Sellins, R.N. Germain, C.G.
Fathman, and A.M. Livingstone, manuscript submitted for
publication) appeared to exhibit a very restricted TCR V/3
usage (10, 14). Six independent AadEad restricted clones
specific for residues 110-121 all used TCR Va8.2, D02.1, and
either J02.5 (1/6) or J02.6 (5/6). The use of Va was more
heterogeneous in that at least three different Va and 4 Ja
segments were used by these six T cell clones (14). Analysis
of these clones on nested sets of overlapping synthetic pep-
tides, on peptides substituted at various positions within the
110-121 sequence, and on allogeneic APCs, revealed differ-
ences in antigen fine specificity that couldclearly be correlated
with differences in the VJ or VDJjunctional regions of the
a and i(3 chains, respectively (reference 14; A. Livingstone,
manuscript in preparation) .
To ask whether this very limited heterogeneity was truly
representative of the response in vivo, we analyzed the 110-
121 T cell response oflymph node cells from primed DBA/2
' Abbreviations used in this paper . Mls, minor lymphocyte stimulating; PPD,
tuberculin purified derivative; SpWMb, sperm whale myoglobin.
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dominant useofthe V08 gene elementin the Tcell response
to 110-121 of DBA/2 mice immunized with either SpWMb
or peptide 110-121.
Two differentapproaches were used to ask whetherremoval
of Vo8* T cells could abrogate or alter the T cell response
to this epitope. First, DBA/2 mice were depleted of periph-
eral T cells expressing V08 by administration in vivo of the
mAb F23.1, specific for T cell receptors bearing any of the
three TCRV138 gene elements (15). These F23.1 treated mice
were able to respondto the 110-121peptide but only at fairly
high antigen concentrations. The second approach involved
the breeding ofmice lacking TCR V08genes. The majority
of inbred mouse strains have a full complement of TCR V(3
genes. A few inbred strains and some wild mice, however,
share a deletion on chromosome 6 including VQ5, 8, 9, 11,
12, and 13 (16, 17). Strains with thefull complement ofTCR
V(3 genes have been given the haplotype VRb, while strains
carrying this deletion have been designated V(3'. H-2d mice
homozygous for Vol were generated by crossing the Vol
locus from SWR onto the DBA/2 strain. Although DBA/
2VO' mice have a very restricted TCR V(3 repertoire, they
made an excellent response to peptide 110-121. We discuss
possible explanations for the dominant V08 response in
DBA/2mice, and forthecontrasting resultswith F23.1 treated
and DBA/2Vf a mice.
Materials and Methods
Animals.
￿
DBA/2, C57BL/6 and SWR mice were obtained
from theJackson Laboratory (Bar Harbor, ME) or from the Na-
tional Cancer Institute, (Bethesda, MD). D2.GD mice from the
Jackson Laboratory were bred in the Department of Laboratory
Animal Medicine, Stanford University (Stanford, CA). Malesfrom
8- to 12-wk-of-age were used for all experiments.
Generation of the DBAl2VO, Line.
￿
DBA/2 (H-2d, VRb) mice
were crossed with SWR (H-29, V(3°) mice and the Fl progeny
crossedback to DBA/2. PBLs were typedby cytofluorometric anal-
ysis (see below) usingmAbs specific forMHC and TCR V/3 gene
products. The mAb 1139 binds to I-A9 but not to I-Ad (18) and
therefore distinguished between H-2" and H-21/q progeny. VQbrb
and VR,ib mice were identified by double staining with allophy-
cocyanin-labeled anti-Ly-1 (reference 19, a generous gift from Dr.
Alan Stall, Stanford University, CA) and FITC-labeled F23.1(15).
VRb/b mice, like the parental DBA/2 strain, had about twice as
many Ly-1', F23.1* cells (i.e., V08' T cells) as (DBA/2 x
SWR)F, mice and the Vol" backcross progeny, as a consequence
of allelic exclusionofTCRVa genes(20). Backcrossprogenytyped
as H-2d", Vol", were intercrossed. The progenywere typed with
anti-Ly-1 and F23.1 as described above, and could be categorized
as Vol/., VRaib, or Vol/b. TheDBA/2V0' line wasestablished by
brother/sister mating of Vf3'/a intercross progeny.
Antigens.
￿
The major chromatographic component (#10) was
prepared from type II myoglobinfrom spermwhale skeletal muscle
(Sigma Chemical Co.) by ion-exchange chromatography, as previ-
ously described(21). The 110-121 SpWMbpeptide wassynthesized
using standard solid phase methods. Tuberculin purified protein
derivative (PPD) was purchased from Connaught Laboratories
(Willow Dale, Ontario, Canada).
Cell Lines.
￿
RT 10.3 Cl (22) I-Ed L cell transfectant was a
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generous gift of R.Germain (National Institutes ofHealth (NIH],
Besthesda, MD).
Cell Staining for TCR V/3: Cytofluorometric Analysis.
￿
DBA/2,
SWR and DBA/2Vo' mice were sacrificed, and their peripheral
lymph node cells (5 x 101) were stained in HBSS (Gibco Labora-
tories) with saturating amounts of mAb as previously described
(23, 24). Sources and specificities oftheantibodies were: antiV02
(B20.6,Dr. B. Mallisen, INSERM-CNRS, Marseille, France), V(33
(KJ25) (25), V(34 (KT4) (26), Vab (RR4-7)(27), VO7 (TR310)
(28), Va8 (F23.1) (15), V8.2 (F23.2) (29), Va14 (14.2) (30);
biotinylated Ly-1 (Becton DickinsonandCo., Mountain View, CA);
fluorescein conjugated goat anti-mouse, anti-rat, anti-hamster Ig,
and Texas Red-streptavidin (Caltag Laboratories, SanFrancisco, CA).
After staining, fluorescence wasanalyzed on a highly modified dual
laser FRCS IV® (Becton Dickinson and Co.). Controls included
cells stained with secondary reagents alone and the background
values were subtracted. Ficoll-enriched T cells from DBA/2, and
DBA/2V0' 110-121 SpWMb T cell lines, were analyzed with the
same antiTCR V(3 mAbs.
Preparation of CD4' Va8' and CD4' V08- LymphNode TCells
from Sperm Whale Myoglobin (SpWMb) and SpWMb 110-121 Im-
munized DBA/2 Mice. 7 d after immunization, the draining in-
guinal lymph nodes of5-6 mice were removed, andthe pooled cell
suspension (5 x 107) was stained with 10 Ag biotinylated anti-
CD4 Ab GK1.5 (31) andwith 10 Ag fluorescein-conjugated F23.1
or F23.2. Cytofluorometric analysis was performed as described
above and 98-99% pure CD4'VO8' or CD4'V08.2' and
CD4'VO8- or CD4'VO8.2 - T cells were sorted for further
analysis.
F23.1 Antibody Depletion in DBA/2 Mice.
￿
On day 0 and after
48 h 500 Ag mAbF23.1 was injected i.p.into DBA/2 mice. Deple-
tion wasassayed on Ficoll-enriched, redbloodcell depleted, PBMCs
before injectionat 24 and 72 h, andday 10 following thefirst mAb
injection by two-colorstaining with GK1.5 andF23.1 as described
above. V/38-depleted mice were immunized 72 hafterthe first in-
jection of F23.1, with the SpWMb 110-121 peptide as described
above.
Proliferation Assays.
￿
T cell proliferative responses to SpWMb
and the peptide 110-121 were determined as follows: sex and age
matched DBA/2, DBA/2VO', and F23.1 depleted DBA/2 mice
were immunized in the base of the tail with the appropriate Ag
(50-100pg) emulsified in CFA (Gibco Laboratories). 7 d after the
immunization, draining lymph node cells (5 x 101) were cultured
in flat-bottom 96-well microtiter plates with various concentra-
tions of Ag. The cultures were pulsed with 1 ACi of ['H]thymi-
dine per well on day 3 of culture and harvested 16 h later. The
SDs were within 10% of the mean value. All experiments were
repeated at leastthreetimes with similarresults. To determine MHC
restriction, lymph node cells were preincubated with 1-2 ttg/ml
of anti-I-Eat, 14.4.45 (32) and anti-I-Aad, MKD6 (33) (a
generous gift from D. Sachs, NIH, Bethesda, MD) protein A
purified mAbs for 2 h. Control wells included cells without Ag
to determine background proliferation; cells with PPD (50-100
Fig/ml) to assess priming efficiency and allogeneic MHC Ag (0.5
x 106 irradiated C57BL/6 (3,000 rad) spleen cells) for prolifera-
tive responses.
4-5
￿
x
￿
10^ sorted V08' or V08.2'/CD4' and V08- or
V08.2-/CD4' SpWMb or SpWMb 110-121 primed DBA/2
lymph node cells were cultured with 5 x 101 irradiated'(3,000
rad) spleen cells without antigen or with SpWMb, SpWMb 110-
121, or PPD as described above. To determine MHC restriction,
lymph node cells were incubated with autologous DBA/2 spleen
cells that express both I-Ad and I-Ed or with D2.GD spleen cellswhich bear only I-Ad MHC class II molecules. Blocking experi-
mentswith anti-class II mAbs were carried out as described above.
All assays were performed in RPMI 1640 (Whittaker M.A. Bio-
products, Walkersville, MD) supplemented with 10 mM Hepes
(Gibco Laboratories) 10% FCS or 0.5% normal mouse serum where
indicated, 2 MM L-glutamine and 5 x 10 -5 M 2-ME (Sigma
Chemical Co.).
DBA/2VO° 110-121 T Cell Lines.
￿
SpWMb 110-121 specific T
cell lines were established from individualSpWMb 110-121 primed
DBA/2V,fl' mice as previously described (21). Briefly, 2-3 x 106
lymph node cells from immunized mice were cultured for 10 d
in the presence of 5 1.M SpWMb peptide 110-121 and propagated
by periodic cycles of stimulation and rest (21). 2 x 104 rested and
Ficoll-enriched T cells were tested in proliferation assays as described
above.
Results
The Predominant In Vivo Response to Peptide 110-121 Involves
V08+ T Cells. In our original analysis of the DBA/2 re-
sponse to SpWMb, we identified six independent T cell clones
specific for the 110-121 epitope. While this epitope overlaps
considerably with the I-Ad restricted 106-118 epitope, first
identified by Berzofsky and colleagues (34-36), the two could
be easily distinguished using myoglobin from different spe-
cies and overlapping sets of synthetic peptides (reference 14;
A. Livingstone, manuscriptin preparation). Experiments using
antigen presenting cells from intra-MHC recombinant mouse
strains, and inhibition with mAbs, originally suggested that
the 110-121 clones were I-Ed restricted (10, 14). A more ex-
tensive analysis with mAbs and with class II-transfected L
cells has now shown that these clones are restricted by the
isotype mixed AadEad molecule (Ruberti, G., K. Sellins,
R.N. Germain, C.C. Fathman, and A.M. Livingstone, manu-
script submitted for publication).
All six ofthe 110-121 specific clones expressed TCR (3 chains
using V08.2, D02.1, and either J02.5 (1/6) or J#2.6 (5/6)
(14). To see whether the use of the TCR V08.2 gene seg-
ment to recognize the 110-121 epitope accurately reflected
the specificity of the T cell response in vivo, DBA/2 mice
were immunized with either the intact protein or with the
110-121 peptide. 98-99% pure populations of CD4+/
V/38+, CD4+/V08.2+ or CD4+/VO8 - , CD4+/VO8.2- T
cells were sorted from the draining lymph nodes, and assayed
against SpWMb or peptide 110-121 presented by DBA/2
APCs. In contrast to longterm T cell culture, very little se-
lection for T cell clones occurs under these conditions. The
results (Fig. 1-3) showed that the response to peptide 110-
121 lay almost entirely within the CD4+/V/d8+ population.
CD4+/Va8- from mice immunized with SpWMb made
little response to SpWMb, and no response at all to peptide
110-121 (Fig. 1) . CD4+/V(38.2 - cells made a slightly
stronger response to SpWMb, but again, there was little, if
any proliferative response to peptide 110-121 (Fig. 2). In mice
immunized with peptide 110-121, the response also lay en-
tirely in the CD4+/VO8+ population (Fig. 3). In each
experiment, the CD4+/VO8- and CD4+/Va8+ popula-
tions made comparable responses to PPD. In multiple ex-
periments, no significant difference in the magnitude of the
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Figure 1.
￿
Selection for V08+ cells in the 110-121 SpWMb response in
vivo (I). Afterimmunization of five DBA/2 mice with SpWMb in CFA,
the pooled local lymph nodes(LN) were removed and LN cells were sorted
by fluorescence-activated cell sorting into V08+ (A and C) and V08-
(B and D) helper T cell populations usinglabeled antibodies as described
in Material and Methods. Both populations were stimulatedwith SpWMb
([1), 110-121 SpWMb (/), or PPD (0) and syngeneic 3,000rad irradi-
ated DBA/2 (A and B) or D2.GD (C and D) spleen cells. The results
shownare the mean values of triplicate measurements and are a represen-
tative example of three independent experiments.
PPD or allo (anti-C57B1/6) response was observed between
the V08+ and V,fl8- populations (data not presented).
These sorted populations were also assayed on D2.GD spleen
cells. This strain has a recombinant MHC haplotype bearing
a defective Ea gene (37-38). It therefore cannot express I-Ed
or Aftal class II molecule. The response in every case was
comparable with that seen on DBA/2 spleen cells, suggesting
that a substantial part of these responses was restricted by
I-Ad, or possibly by AadEgd. However, the 110-121 response
of unsorted lymph node cells from DBA/2 mice primed with
either the peptide 110-121 or with whole myoglobin was
significantly inhibited by the monoclonal antibody 14.4.4S
(specific for Ea chains) as well as by the Aod specific anti-
body MKD6 (data not shown) . Thus at least part of the
DBA/2 response to peptide 110-121 was restricted by class
II molecules involving the Ead chain (i.e., I-Ed or A/ddEad).
Sperm Whale Myoglobin (SpWMb) 110-121 T Cell Responses
in Anti-V/38 Antibody-Treated DBA/2 Mice. The experiments
described above confirmed previous results showing that the
majority of the response to peptide 110-121 was contained
within the V08+ population. We therefore asked whether
DBA/2 mice that lacked V08+ T cells could respond to
peptide 110-121. Our first approach was to remove V08+
peripheral T cells by treatment in vivo with the antiV08
A
CD4+/V98+ CD4+/VP8-
to,
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s
0
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Figure 2 .
￿
Selection for Vfl8+ cells in the 110-121 SpWMb response in
vivo (II) . Five DBA/2 mice were primed with SpWMb and the V08.2*
(A and C) and V08 .2 - (B and D) helper T cell populations were ana-
lyzed as described in Fig. 1 in the presenceofSpWMb ((]), 110-121SpWMb
(/), or PPD (0) on DBA/2 (A and B) and D2.GD (C and D) APCs .
specific mAb, F23.1, which depletes Va8+ T cell from the
peripheral blood (15) . Depletion of F23.1+ peripheral T cells
is 99% complete 3 d after i.p. administration of a 1 mg dose
and is still at this level on day 10 (Fig. 4) . In three experi-
ments, V08 depleted DBA/2 mice were primed with the 110-
121 peptide and proliferation of their individual or pooled
lymph node T cells was analyzed in comparison with the
normal DBA/2 primed lymph nodeT cell response. Asshown
in Fig. 5, F23.1 depleted mice responded to the 110-121 pep-
en
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Figure 3 .
￿
Selection for V08+ cells in the 110-121 SpWMb response in
vivo (III) . Five DBA/2 mice were primed with the 110-121 SpWMb pep-
tide in CFA . V08+ ($) and V,88- (-/-) populations were sorted as
described in Fig. 1 and the response to SpWMb peptide 110-121 was ana-
lyzed . V08+ (EI) and V08 - (N) PPD responses were included to assess
priming efficiency.
tide but the response was very poor compared with that of
the untreated controls and could only be seen at high peptide
concentrations; lymph node cells from F23.1-treated mice
needed at least five times more antigen than cells from un-
treated mice to give comparable responses.
Generation and Characterization of the DBAl2VO° Line.
An alternative way to look at the 110-121 response in DBA/2
mice lacking V08+ peripheral T cells involved the genera-
tion of a DBA/2 mouse line that carried a genetic deletion
of the V08 gene family. Most inbred mice strains have a full
complement of TCR V/3 gene segments (haplotype Vob ),
but several strains have a large deletion (haplotype V/3') in-
volving the TCR V05, 8, 9, 11, 12, and 13 gene segments
(16) . DBA/2 has the VOb haplotype while the SWR strain
carries the deleted haplotype VOa . The breeding of the
DBA/2VO' line is described in detail in Materials and Me-
thods . Briefly, SWR mice were mated to DBA/2, and the
(SWR x DBA/2)Ft progeny were backcrossed to DBA/2 .
The backcross progeny were typed forMHC and V(3 haplo-
Figure 4. Depletion of V08+,
CD4+ T cells with mAb F23 .1 in
vivo . In (A) and (B) anti-CD4 vs . anti-
V08 (F23 .1) FRCS analysis is plotted .
The boxed regions represent CD4+
F23.1+ cells . In (C), anti-CD4 is
plotted vs. anti-mouse Ig to demon-
strate clearance of surface F23.1 (a
mouse IgG 2a-positive antibody) .
Depletion of CD4+ F23.1+ cells was
assayed on PBLs: At 72 h, the deple-
tion of F23 .1 peripheral T cells is 99%
complete (the boxed areas) 3 d after i.p.
administration of a 1 mg dose and is
still at this level at day 10 . Two-color staining data are provided as "contour plots" in which the levels of green and Texas-red fluorescence per cell
define their location on a two-dimensional surface. Each contour line represents a 5% frequency of cells with a given fluorescence intensity.
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Figure 5.
￿
Proliferative response ofDBA/2(0)andF231 depleted DBA/2
mice (O, *). Five mice were primed with the 110-121 SpWMb peptide
and theirpooled lymph node cells assays in the presence of different an-
tigenconcentrations of the 110-121 peptide. F23.1 depleted mice were treated
with two different antibody preparations: (+)concentrated F23.1 from
tissue culturesupernatant and(O)protein-A purified F23.1 mouseascites.
This is a representative exampleofthree experiments in whichpooled and
individual lymph node cells were analyzed. The SDs were within 10%
of themean values. Complete mediasupplemented with 0.5% freshmouse
serum was used in these assays.
types by cytofluorometric analysis of PBLs. H2d/d, V)36/a
progeny were intercrossed and the Vß2/a progeny selected as
the parent of a DBA/2Vß2 line. This line still carried a sub-
stantial genetic contribution from the SWR strain. How-
Table 1.
￿
Peripheral Expression of V,ß Domains in DBA/2,
SWR, and DBA/21l,ß' Mice
Frequency of Vß gene element expression among Ly-l' Tcells. Staining
andflow cytometric analysis were carried out on peripheral lymph node
cells as described in Materialsand Methods;thebackground values were
subtracted.
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ever, both the inbred DBA/2 strain and the DBA/2Vß' line
demonstrably shared a number ofloci known to have impor-
tant effects on the intrathymic selection of the T cell reper-
toire. Both lines expressed I-Ed molecules, and also the
minor lymphocyte stimulating (Mls) Mls-1a and Mls-2a an-
tigens. All o£ these antigens cause intrathymic deletion of
Tcells expressing particular TCR Vß genes during develop-
ment of the T cell repertoire. Cytofluorometric analysis of
TCR Vß expression on peripheral lymph node cells (Table
1) showed that both lines had low numbers of Vß3, Vß6,
and Vß7 cells, consistent with deletion by Mls-1a and Mls-2a
(25, 27, 28, 39, 40, 41), while Vß2, Vß4, and Vß14 expres-
sion was higher in DBA/2 Vß' mice than in DBA/2 mice.
DBA/2Vß° Mice Make a T Cell Response to Peptide 110-
121. DBA/2 and DBA/2Vß2 mice were immunized in par-
allel with peptide 110-121, and cellsfrom thedraining lymph
nodes were assayedforproliferative response to this peptide.
As shown in Fig. 6, the magnitude of the response made
by DBA/2Vß2 mice was at least as great as that made by
DBA/2mice. Twolinesofevidence suggested that asignificant
proportion of this response might be restricted by I-Ad.
First, the response to peptide 110-121 presented by D2.GD
spleen cells was as strong as that seen with DBA/2 antigen
presenting cells (Table 2). Second, in experiments wheremAbs
were used to block the response of DBA/2 Vß2 T cells to
peptide 110-121, MKD6 inhibited the response more effec-
tively that 14AAS (Table 3); in similar experiments using
these antibodies to inhibit the response of AßdEad-
restricted, 110-121 specific clones, 14.4.4Sinvariably blocked
the response far more effectively than MKD6 (Ruberti, G.,
K.S. Sellins, R.N. Germain, C.G. Fathman, andA.M. Living-
0
NM 110-121
Figure 6.
￿
DBA/2Vß2 mice response to the 110-121 SpWMbpeptide.
Proliferative response of pooled DBA/2 (-*-) and DBA/2V)32 ($)
lymph node cells to different concentrations of the 110-121 peptide and
to PPD(*, O). Thedata representthemean oftriplicate determinations
andare representative offive experiments in which pooled andindividual
lymph node cells were assayed. TheSDs were within 10% of the mean
values.
vo
Percentage
DBA/2
of positive T cells
SWR
(mean ± SE)
DBA/2V0'
V02 8.0 ± 0.2 14.9 ± 0.8 15 .8 ± 0.8
V03 0.6 ± 0.1 2.4 ± 0.4 0.2 ± 0.1
V04 9.2 ± 0.3 9.7 ± 0.3 19.1 ± 0.5
Vß6 0.4 ± 0.2 8.1 ± 0.8 0.4 ± 0.2
Vß7 0.4 ± 0.2 5.3 t 0.8 0.6 ± 0.2
Vß14 9.9 0.4 9.2 ± 0.8 15.7 ± 0.1Ficoll-enriched T cells were cultured with different APCs: DBA/2 spleen cells (I-Ad+ and I-Ed*) (0.5 x 105 c/well (A), D2.GD spleen cells (I-Ad+
and I-Ed-) (0.5 x 105 c/well), (B) RT 10.3 C1 (I-Ad- and I-Ed.) transfectants (0.5-2 x 105 c/well), (C) and the 110-121 SpWMb peptide as
described in Materials and Methods . Each panel shows a representative example of several experiments on five individual T cell lines.
stone, manuscript submitted for publication). However, 110-
121 specific T cell lines isolated from these mice did respond
to the PT 10.3 C1 I-Ed transfected fibroblast line (Table 2).
In these experiments, responses were seen only at very high
peptide concentrations, but such APCs are often very poor
stimulators of T cell linesand clones, although they may stimu-
late T cell hybridomas quite effectively. To date, limiting di-
lution of five DBA/2VO' 110-121 specific T cell lines has
yielded only I-Ad restricted T cell clones that recognize the
110-121 peptide presented by D2.GD spleen cells (data not
shown). Together, these results suggest that only a small part
of the DBA/2VO' response recognizes the 110-121 peptide
in the context of EcxdEod or AodEad class II MHC mol-
ecules.
Discussion
This study was undertaken to analyze the T cell response
in vivo of DBA/2 mice to the 110-121 epitope of SpWMb
Table 3.
￿
Antibodies Blocking Studies on DBA/2V,& T Cell Lines
and to investigate the basis for the extremely restrictedTCR
repertoire observed in this response in vitro. Our original
results, using a panel of independent T cell clones specific
for three distinct epitopes on SpWMb, showed that 11/14
clones expressed a V~8 gene segment (10). Moreover, the
response to one particular epitope, defined by residues 110-
121 and restricted by AodEcid, showed extremely limited
TCR3 gene segment usage. All six independent clones specific
for 110-121/AodEcid used V08.2 and D02.1, together with
eitherJ02.5 orJ02.6 (14). The experiments described in this
paper analyzed the response to peptide 110-121 in vivo in
normal DBA/2 mice and in DBA/2 mice unable to use the
TCR V(38 gene family.
The first experiments confirmed that the very strong bias
towards TCR V08 expression observed in the panel of T cell
clones was also found in vivo. This V/38 restricted response
was seen not only in the response to peptide 110-121, but
also in the response to whole myoglobin. These experiments
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Ficoll-enriched resting T cells were cultured with syngeneic spleen cells andwith differentantigen concentrations of the 110-121 peptide as described
in Materials and Methods. APCs were preincubated with 14.4.4S (anti-I-Ea) or MKD6 (anti-I-Aod) mAb (1-2 F+g/ml). Background 3H incorpora-
tion in the absence of antigen ranged from 1-2 x 103 cpm/well and has been subtracted. This is a representative example of five experiments on
five individual DBA/2VO°-derived T cell lines.
Table 2. Proliferative Responses of DBA/2V& T Cell Lines on I-Ed', I-Ad-, and on I-E`
Ag
I-Ad' Antigen-Presenting Cells
0 (JAM) 0.4 (ttM) 2 (/M) 10 (',M) 50 (1M)
A 731 4,202 22,670 30,670 59,364 69,277
735 7,680 27,762 40,141 73,411 90,722
B 731 4,357 25,323 32,201 54,510 62,308
735 3,961 29,563 43,533 80,082 92,473
C 731 718 604 790 1,466 10,538
735 716 706 680 1,489 12,705
12 x 10-5
(-,M)
64 x 10-4
(AM)
32 x 10-^
(1,M)
Ag
16x10-1
(UM)
8x10 -2
(AM)
4x10-'
(AM)
2x10'
(AM)
731 4,992 9,279 7,883 21,305 34,806 45,349 41,601
+ 14.4.45 MAb 4,392 6,851 6,400 15,529 28,770 39,083 35,264
+ MKD6 MAb 2,164 2,912 3,839 9,196 22,367 31,773 30,478
735 12,245 40,974 60,188 63,713
+ 14.4.4S MAb 8,924 36,505 60,401 64,646
+ MKD6 MAb 6,196 25,827 52,983 53,652also showed that I-Ad (and perhaps AadEfd) in addition to
the hybrid AadEotd, could restrict T cell recognition of pep-
tide 110-121. This result is of particular interest since Sette
et al. (42-43) have shown that residues within the sequence
111-118 allowed peptide binding to I-Ad and I-Ed molecules.
These current studies emphasize the importance ofanalyzing
responses with T cells taken directly from the animal; the
initial analysis, where clones were isolated after several rounds
of in vitro restimulation, only gave AadEctd restricted 110-
121 specific T cell clones (Ruberti, G., K.S. Sellins, R.N.
Germain, C.G. Fathman, and A.M. Livingstone, manuscript
submitted for publication).
In the past few years, several groups have reported strong
associations between expression of particular TCR V0 do-
mains and MHC restriction (4, 5, 7, 10). However, expres-
sion of V08 gene segments alone cannot be sufficient to de-
termine the specificity of the restriction, since members of
the V08 family are expressed in other antigenic systems by
T cells with disparate MHC restriction specificities. The Va8.2
gene segment, for instance, is used by both I-A, I-E, and class
I restricted T cell clones and hybridomas. DBA/2 mice ex-
press I-Ed, Mls-1a, and Mls-2' antigens and so the majority
of T cells expressing V(33 (25, 39), V#5 (44-46), V06 (27,
40), V#7 (28, 41), Vf8.1(29), Va9 (41, 47), V,311 (48, 49),
and probably V012 and 16 (41, 50) were deletedduring thymic
maturations. Despite this limitation, the DBA/2 peripheral
T cell repertoire includes T cells expressing gene segments
from at least eight other V,3 families in addition to V,Q8.
The predominant use of TCR Vf8 gene segments in the
DBA/2 response to peptide 110-121 could be explained in
several ways. One possibility was that V,68.2, perhaps in as-
sociation with particular Df and/or Ja segments, was the
only available TCR V/3 gene element that could be used to
construct a receptor recognizing peptide 110-121. If so, then
DBA/2 mice lacking peripheral V#8 T cells would be un-
able to make any 110-121-specific response. Alternatively, the
predominance of Va8+ T cells in the DBA/2 response to
peptide 110-121 could be due to constraints imposed during
rearrangement of TCR V/3 gene segments, or to as yet un-
determined regulatory interactions during the establishment
of the peripheral T cell repertoire. If so, Va8 - DBA/2 mice
might make a 110-121-specific response using an alternative
TCR V# gene segment(s).
We, therefore, looked at the 110-121 response in DBA/2
mice depleted of V08+ T cells, by treatment with a V08-
specific mAb and in DBA/2 mice carrying a genetic deletion
of the entire TCR V08 family.
These two approachesgave very different answers. DBA/2
mice depleted of peripheral Vf8 + T cells by antibody treat-
ment were able to make a 110-121-specific response, but this
was considerably weaker than that seen in control mice, and
could only be detected at relatively high antigen concentra-
tions. As discussed above, this Va8 - response was not seen
at all in normal DBA/2 mice. One explanation is that in
DBA/2 mice, V08 - T cells specific for 110-121 are present
at low frequency, or have low affinity (or both) compared
with V#8+ 110-121-specific T cells. Immunization of un-
treated DBA/2 mice preferentially expanded the Vf8+ re-
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sponse, effectively masking any V#8 - component; in the
absence of V08+ cells, the V08- cells were expanded
sufficiently to be detected. This explanation of data suggests
the possibility that "high affinity" and/or more frequent T
cell clone responses override potential lower affinity and/or
lower frequency receptor(s) engagements.
The response in DBA/2 mice lacking TCR V08 gene ele-
ments was strikingly different. The DBA/2VO' mice pro-
duced by crossing the V,Qa locus from SWR onto the
DBA/2 background had a very severely restricted TCR V(3
repertoire. As a consequence of the genetic deletion within
the VR locus, they had no T cells expressing V05, V08, V09,
V(311, V012, or V#13 gene elements; in addition, the majority
of V03, V06, V07, V017a (51), and probably V016 T cells
were deleted intrathymically during thymocyte maturation,
since these mice expressed I-Ed, Mls-1', and Mls-2' antigens.
Despite this limitation, the DBA/2V#' mice made a normal
T cell proliferative response to peptide 110-121 when com-
pared to DBA/2VOb mice. However, preliminary data sug-
gested that there was a shift of MHC restriction. The
DBA/2VO' response to 110-121 appeared to be restricted al-
most entirely by I-Ad, although inhibition by the antibody
14.4.4S, and a very weak response to an I-Ad, I-Ed' APC
line suggested that a small component ofthis response might
be restricted by I-Ed and/or perhaps by the hybrid molecule
AfdEad. Further analysis will be necessary to investigate the
presence ofT cell responses to hybrid molecules and the 110-
121 peptide in DBA/2V#' mice and whether this Ag/MHC
complex is recognized at all. Cytofluorometric analysis of 110-
121-specific T cell lines from DBA/2V/3' mice, using mAb,
specific for V02, V03, V06, Va7, and V014, failed to iden-
tify any dominant TCR V,Q gene usage.
These experiments demonstrated very clearly that the use
of TCR Va8+ receptors in the DBA/2 response to peptide
110-121 was not determined by any structural requirement.
Since DBA/2Vf' mice were able to make a strong V08 -
response to peptide 110-121, the absence of a comparable re-
sponse in DBA/2 mice must be explained. All the TCR Va
genes expressed on peripheral T 'cells in DBA/2V/3' mice
should in theory also be present in DBA/2 mice. Since the
DBA/2V0' animals used in these experiments were only at
the first backcross level, we cannot rule out the possibility
that the 110-121 response in these mice is mediated by T cells
positively selected by non-MHC antigens derived from the
SWR strain. This seems rather unlikely, since the cotolerogens
described to date cause deletion (45, 49) rather than positive
selection. T cell receptor VO polymorphism between V/3'
and Vob strains have been observed by RFLP and sequence
analysis (16, 52-53) and such germ-line encoded differences
in the TCR V/3 repertoire might play a role in the SpWMb
110-121 immune responsiveness. It is unlikely that polymor-
phisms within TCR Vot genotype (54-56) play a significant
role in the dissimilarities between the DBA/2 and DBA/2
V/3' response to SpWMb 110-121. Although the Va geno-
type of the DBA/2VQa mice was not analyzed, the ability
of multiple Vcx's to pair effectively with V(3 8.2 in the DBA/2
mice in response to SpWMb 110-121 peptide suggests that
limitations imposed in We use are less demanding. We are,however, continuing to cross the Vß' haplotype onto the
DBA/2 background to create a congenic line to address these
questions as well as a possible role ofJß and Ja polymor-
phism in the 110-121 immune response.
An additional explanation is that those V#8 - cells re-
sponsible for the 110-121 specific response in the F23.1-treated
DBA/2 mice are present at considerably higher frequency in
the DBA/2Vß' mice, and are therefore able to make a much
stronger response. Because peripheral T cells in DBA/2 Vß'
mice can express only about half the number of Vß gene
expressed in DBA/2 mice, cells expressing a particular Vß
gene would be expected to be about twice as frequent in
DBA/2Vß' mice as in DBA/2 mice in the absence of selec-
tive pressures. Cytofluorometric analysis of TCR Vß expres-
sion in lymph node cells confirmed this expected level of ex-
pression for Vß families that could be analyzed by FRCS.
The percentage of T cells expressing Vß2, Vß4, and Vß14
was approximately twice that seen in DRA/2 mice (Table
1). We are currently investigating the possibility of restricted
Vß use in these two models by comparing the fine specificity,
MHC restriction and TCR Vß gene usage of the 110-121
response in F23 .1 treated DBA/2 mice versus DBA/2Vß1
mice.
It is also possible that mechanisms of TCR ß gene seg-
ment rearrangement may favor the production of functional
receptors using particular gene elements. For example, the
deletion of about 10 TCR Vß gene segments in the Vß1
haplotype might affect the repertoire by allowing preferen-
tial Vß rearrangements not seen at high frequency in the
Vßb haplotype. Preferential usage of the 3'-most VH gene
has been observed in VDJ rearrangement in murine and human
B cell lineage early in ontogeny (57-59). B cells in both im-
mature and adult rabbits preferentially use VH1 in VDJ rear-
rangement (60). Moreover, biased expression ofJH-proximal
VH genes occurs in the newly generated repertoire of neo-
natal and adult mice (61). The proximity of the VH1 to D
and JH gene or the more effective combinatorial association
withjunctional regions have both been postulated to explain
the more frequent expression ofthe VH1 gene (60). It is not
yet known whether, during thymic development before se-
lection, there is a preferential rearrangement of particularVDJO
and VJa gene element combinations or whether certain com-
binations are more affected by positive or negative selection
pressures. Examination of ß chain rearrangements in a large
panel of T cell clones and hybridomas with different
specificities has demonstrated that the majority of expressed
ß chains use aJß2 gene segment (62). Moreover, a homoge-
nousjunctional sequence ofVa14 has been recently reported
in naive mice (63). This may be a function of selective pres-
sures or a mechanistic gene rearrangement which occurs be-
fore selection. If there is a "mechanistic" nonselective rear-
rangement ofthe VDJO elements during thymic development
which influences the peripheral repertoire, it is likely that
the Vß' haplotype, with the genomic deletion, may play a
crucial role in the VDJO combination frequencies and thus
explain the equivalent SpWMb 110-121 epitope response in
DBA/2 and DBA/2Vß' mice. Experiments are currently
under way to address whether "mechanistic" rearrangements
which precedes selective pressures may explain these data.
Several previous studies have analyzed responses where there
is predominant use of a particular TCR Vß gene segment,
to ask what happens when T cells expressing the Vß gene
in question are not available (64-67). As in our study com-
paring DBA/2 and DBA/2Vß1 mice, it was found that a re-
sponse was made using alternative Vß gene segments. In these
experiments, however, T cells expressing the preferred Vß
gene segment were deleted intrathymically through recogni-
tion ofMls antigens. They thus compared T cell populations
that were selected in Mls+ versus Mls - thymic environ-
ments, and therefore potentially had quite distinct repertoires.
The study described here compared peripheral T cell popula-
tions that had both matured in H-2d, Mls-11, Mls-21 en-
vironments, and therefore (with the reservation about SWR-
derived antigens mentioned above) were subject to the same
positive and negative selection.
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